Otros idiomas AstraZeneca PLC

Acciones

AZN

GB0009895292

Farmacéuticos

Mercado cerrado - London S.E. Otros sitios de cotización 17:35:29 15/01/2026			Variación 5 días	Varia. 1 de enero.
14.026,00 ^GBX	-2,23 %		-1,39 %	+1,71 %

15/01	El exdirector general de Emergent BioSolutions, demandado por uso de información privilegiada por la Fiscal General de Nueva York	MT
15/01	Las bolsas cierran en verde tras sorpresas positivas en la manufactura estadounidense	AN

Otros idiomas

15/01	N.Y. Attorney General Sues Former Emergent Biosolutions CEO for Insider Trading -- Update
15/01	Emergent BioSolutions' Former CEO Sued for Insider Trading by New York Attorney General
15/01	N.Y. Attorney General Sues Former Emergent Biosolutions CEO for Insider Trading
15/01	Stocks in green as US manufacturing surprises
15/01	Pharma sector doubles down on AI amid hopes of slashing costs, timelines
15/01	European Equities Traded in the US as American Depositary Receipts Little Changed in Thursday Trading
15/01	AstraZeneca, Abu Dhabi Biobank to Advance Precision Medicine, New Healthcare Practices
14/01	Sector Update: Health Care Stocks Higher Late Afternoon
14/01	Sector Update: Health Care Stocks Advance in Afternoon Trading
14/01	Sanofi CEO says expects flu-COVID combo vaccines in 2027-2028 to drive next surge in vaccine uptake
14/01	L'Europe finit dans le désordre une séance indécise, Wall Street pénalisée par les banques
14/01	Point marchés-L'Europe finit dans le désordre une séance indécise, Wall Street pénalisée par les banques
14/01	London's FTSE 100 notches new high on mining, healthcare boost
14/01	European Stocks Close Mixed in Wednesday Trading; Rising UK Business Growth 'Good Omen'
14/01	US, European regulators set principles for 'good AI practice' in drug development
14/01	Sector Update: Health Care Stocks Mixed Premarket Wednesday
14/01	Sector Update: Health Care
14/01	Exchange-Traded Funds, Equity Futures Lower Pre-Bell Wednesday Ahead of Expected Supreme Court Decision on Tariffs
14/01	Point marchés-Wall Street vue en repli avant des indicateurs, l'Europe dans le désordre
14/01	Modella AI Announces Acquisition by AstraZeneca to Advance AI-Driven Oncology R&D at Global Scale
14/01	Daiichi Sankyo - TROPION-Lung17 TROP2 Biomarker Directed Phase 3 Trial of DATROWAY Initiated in Patients with Previously Treated Advanced Nonsquamous Non-Small Cell Lung Cancer
14/01	Hutchmed China hails lung cancer trial results published in Lancet
14/01	Miners lift FTSE 100 ahead of US PPI
14/01	London's FTSE 100 touches fresh peak as miners, healthcare gain; Pearson drops
14/01	Polar Capital Global Healthcare Trust beats benchmark; demand "robust"

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripciones Comunicados Publs. oficiales Otros idiomas Artículos de MarketScreener Estrategias MarketScreener Ideas de trading

Filtros

Acciones

Directora financiera de AstraZeneca sobre estrategia de fusiones y adquisiciones y mercado de la obesidad

13 de enero 2026 a las 23:34

ASTRAZENECA : buen rendimiento, pero precio adecuado

19 de noviembre 2025 a las 13:43